PO.TB10.13 · 肿瘤生物学
微生物群激活簇状细胞-感觉神经元反馈环以促进食管胃结合部(EGJ)肿瘤发生
Microbiotas activate a tuft cell-sensory neuron feedback loop to promote esophagogastric junction (EGJ) tumorigenesis
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:食管胃结合部(EGJ)腺癌在发达国家发病率上升。尽管饮食和反流有所贡献,但微生物-神经元机制仍不明确。
方法:对40对配对的人EGJ肿瘤及邻近组织进行代谢组学和16S rRNA测序,并对五对进行单细胞RNA测序。机制研究采用Barrett食管的pL2-IL1B小鼠模型、Cck2r-CreERT2小鼠标记EGJ祖细胞,以及与p53 R172H;pL2-IL1B杂交以提供易患肿瘤的背景。Dclk1-CreERT2靶向簇状细胞(Tuft细胞),而Trpv1-Cre、hM3Dq和Ramp1 flox用于研究感觉信号。其他品系(Cck2r-CreERT2; Ramp1 flox/flox、Dclk1-CreERT2; Cox1 flox/flox; Cox2 flox/flox、Pou2f3-CreERT2; DTA)解析簇状细胞-神经元-上皮回路。P. melaninogenica定植和脱氧胆酸(DCA)补充模拟微生物-代谢效应。钙成像、磷酸化ERK染色和簇状细胞-神经元共培养评估功能性信号。
结果:EGJ肿瘤富含厚壁菌门/拟杆菌门和Prevotella,而邻近组织含有变形菌门和Helicobacter。Prevotella丰度与花生四烯酸正相关,与色氨酸代谢物负相关。单细胞数据显示上皮、免疫和代谢集群,增殖细胞中富集胆汁酸和脂肪酸通路。P. melaninogenica与富含胆汁酸、易患癌的环境相关,被选作机制研究。DCA单独即增强pL2-IL1B小鼠的EGJ异型增生。口服P. melaninogenica定植于EGJ,经DCA进一步增加,形成胆汁酸生态位。定植放大CGRP⁺神经元信号,扩增簇状细胞,并加重异型增生。易患肿瘤的Cck2r-CreERT2; p53R172H; pL2-IL1B小鼠显示更多簇状细胞-CGRP⁺接触,拟时序分析表明Cck2r⁺向簇状细胞分化增强。在离体类器官中,激活Dclk1⁺; hM3Dq⁺簇状细胞升高PGE₂/NGF分泌,强化簇状细胞-神经接触,并诱导共培养的Trpv1⁺; GCaMP6s⁺ DRG神经元钙内流。Trpv1⁺神经元共表达CGRP和EP4。在Trpv1-Cre; hM3Dq; pL2-IL1B小鼠中,DCA + CNO联合处理进一步增加异型增生。簇状细胞消融(Pou2f3-CreERT2; DTA)、簇状细胞特异性Cox1/2缺失或Cck2r⁺细胞中Ramp1缺失抑制P. melaninogenica诱导的异型增生,表明阻断簇状细胞-神经元-祖细胞轴可阻止肿瘤进展。
结论:我们定义了一个驱动EGJ肿瘤发生的微生物群-胆汁酸-簇状细胞-神经元反馈环。P. melaninogenica和DCA激活簇状细胞释放PGE₂/NGF,刺激EP4-CGRP/Ramp1信号并促进上皮异型增生。破坏此回路抑制肿瘤生长,凸显了EGJ癌预防的代谢-神经元靶点。
查看英文原文 English abstract
Background Esophagogastric junction (EGJ) adenocarcinoma is rising in developed countries. While diet and reflux contribute, microbial-neuronal mechanisms remain poorly defined.
Methods Metabolomic and 16S rRNA sequencing were performed on 40 paired human EGJ tumors and adjacent tissues, and single-cell RNA sequencing on five pairs. Mechanistic studies used the pL2-IL1B mouse model of Barrett's esophagus, Cck2r-CreERT2 mice to label EGJ progenitors, and crosses to p53 R172H ; pL2-IL1B to provide a tumor-prone background. Dclk1-CreERT2 targeted Tuft cells, while Trpv1-Cre, hM3Dq, and Ramp1 flox examined sensory signaling. Additional lines (Cck2r-CreERT2; Ramp1 flox/flox , Dclk1-CreERT2; Cox1 flox/flox ; Cox2 flox/flox , Pou2f3-CreERT2; DTA) dissected the Tuft-neuron-epithelial circuit. P. melaninogenica colonization and deoxycholic acid (DCA) supplementation modeled microbial-metabolic effects. Calcium imaging, phospho-ERK staining, and Tuft-neuron co-cultures assessed functional signaling.
Results EGJ tumors were enriched in Firmicutes/Bacteroidota and Prevotella , while adjacent tissues contained Proteobacteria and Helicobacter . Prevotella abundance correlated positively with arachidonic-acid and negatively with tryptophan metabolites. Single-cell data showed epithelial, immune, and metabolic clusters, with bile- and fatty-acid pathways enriched in proliferative cells. P. melaninogenica , linked to bile-acid-rich, cancer-prone environments, was selected for mechanistic study. DCA alone enhanced EGJ dysplasia in pL2-IL1B mice. Oral P. melaninogenica colonized the EGJ, further increased by DCA, forming a bile-acid niche. Colonization amplified CGRP⁺ neuronal signaling, expanded Tuft cells, and aggravated dysplasia. Tumor-prone Cck2r-CreERT2; p53R172H; pL2-IL1B mice showed more Tuft-CGRP⁺ contacts, and pseudotime analysis indicated enhanced Cck2r⁺-to-Tuft differentiation. In ex vivo organoids, activation of Dclk1⁺; hM3Dq⁺ Tuft cells elevated PGE₂/NGF secretion, strengthened Tuft-nerve contacts, and induced calcium influx in co-cultured Trpv1⁺; GCaMP6s⁺ DRG neurons. Trpv1⁺ neurons co-expressed CGRP and EP4. Combined DCA + CNO treatment in Trpv1-Cre; hM3Dq; pL2-IL1B mice further increased dysplasia. Tuft ablation (Pou2f3-CreERT2; DTA), Tuft-specific Cox1/2 loss, or Ramp1 deletion in Cck2r⁺ cells suppressed P. melaninogenica -induced dysplasia, demonstrating that blocking the Tuft-neuron-progenitor axis halts tumor progression.
Conclusions We define a microbiota-bile-acid-Tuft-neuron feedback loop driving EGJ tumorigenesis. P. melaninogenica and DCA activate Tuft cells to release PGE₂/NGF, stimulating EP4-CGRP/Ramp1 signaling and promoting epithelial dysplasia. Disrupting this circuit suppresses tumor growth, highlighting a metabolic-neuronal target for EGJ cancer prevention.
利益披露 Disclosure
Y. Zeng, None..
P. Zhang, None..
R. Tu, None..
X. Zhi, None..
B. Zheng, None..
J. Qian, None..
H. Zheng, None..
S. Li, None..
H. Y. Kobayashi, None..
Y. Ochiai, None..
M. Hata, None..
J. Lin, None..
J. Arai, None..
L. B. Zamechek, None..
Z. Ye, None..
T. Wang, None.